-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTAY THERAPEUTICS CLOSES $37 MILLION SERIES A FINANCING TO ADVANCE FIRST ORAL DUX4 INHIBITOR FOR FSHD INTO THE CLINIC

路透·10/14/2026 12:00:11

請登錄查看新聞詳情